Emcure Pharmaceuticals Limited has informed the Exchange regarding allotment of 17000 securities pursuant to ESOP/ESPS at its meeting held on March 03, 2026
EMCURE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Emcure Pharmaceuticals has allotted 17,000 equity shares of Rs. 10 face value to eligible employees who exercised their vested stock options under the Emcure Employee Stock Option Scheme 2013. The allotment was approved by the Nomination and Remuneration Committee on March 3, 2026. As a result, the company's paid-up share capital has increased from Rs. 188.57 crore to Rs. 188.59 crore (total shares went from 18,95,72,547 to 18,95,89,547). The new shares carry equal rights as existing shares.
This is a very small dilution — 17,000 shares against a base of nearly 18.96 crore shares (less than 0.001% impact). The allotment signals normal employee benefit activity and is unlikely to affect the stock price or existing shareholders meaningfully.